RecruitingNCT05613608
Full- or broad-spectrum CBD versus placebo for alcohol use disorder
Medication studyAges 21+United StatesAddiction
Understand this study
Who could participate?
Listed age limits: from 21 years.
- Listed locations
- AuroraSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 30, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 180
- Sponsor
- University of Colorado, Denver
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- Over 21 Years
- Official registry ID
- NCT05613608
- Official title
Show the full official title
Alcohol Use Disorder and Cannabis: Testing Novel Harm Reduction Strategies
Recruitment & locations
RecruitingAurora
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is University of Colorado, Denver, a university.
Does this study involve medication?
Yes. The study involves medication, including Cannabidiol and Placebo.
Who can participate?
Listed age limits: from 21 years.
Is this study still recruiting?
The registry lists this study as recruiting.
